Stephen Croskrey - Apr 18, 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role: CEO & Chairman of the Board, Director
Signature: /s/ Stephen A. Martin, attorney-in-fact
Stock symbol: DNMR
Transactions as of: Apr 18, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/12/2023, 05:40 PM
Previous filing: Apr 4, 2022
Next filing: Feb 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNMR	Class A Common Stock	Award		+39.3K	+0.75%		5.3M	Apr 18, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the Agreement and Plan of Merger, dated as of October 3, 2020, by and among Live Oak Acquisition Corp., a Delaware corporation ("Live Oak"), Green Merger Corp., a Georgia corporation and wholly-owned subsidiary of Live Oak, Meredian Holdings Group Inc. a Georgia corporation ("MHG"), Live Oak Sponsor Partners, LLC, as representative for Live Oak, and John A. Dowdy, Jr., as representative of the shareholders of the Issuer, as amended by Amendment No. 1, dated as of October 8, 2020, and Amendment No. 2, dated as of December 11, 2020 (as so amended, the "Merger Agreement"), by and among all the parties thereto, pursuant to which MHG became a direct, wholly-owned subsidiary of Live Oak (the "Merger"), which subsequently changed its name to Danimer Scientific, Inc. (the "Issuer"), 450,000 shares of the Issuer (the "Holdback Shares") were held back from the merger consideration payable to MHG shareholders at the closing of the Merger until...(continued)
F2	(Continuation of Footnote 1)...the final determination of the merger consideration. On April 18, 2022, following such final determination of the merger consideration in the Merger, an aggregate of 344,435 of the Holdback Shares were released and issued to MHG shareholders, and the Reporting Person received Reporting Person's pro rata portion of such Holdback Shares so issued. The issuance of the shares of the Issuer as merger consideration in the Merger, including the receipt of the Holdback Shares reported on this Form 4, was approved by Issuer's board of directors in December 2020 and is exempt under Rule 16b-3.

Content

Pursuant to the Agreement and Plan of Merger, dated as of October 3, 2020, by and among Live Oak Acquisition Corp., a Delaware corporation ("Live Oak"), Green Merger Corp., a Georgia corporation and wholly-owned subsidiary of Live Oak, Meredian Holdings Group Inc. a Georgia corporation ("MHG"), Live Oak Sponsor Partners, LLC, as representative for Live Oak, and John A. Dowdy, Jr., as representative of the shareholders of the Issuer, as amended by Amendment No. 1, dated as of October 8, 2020, and Amendment No. 2, dated as of December 11, 2020 (as so amended, the "Merger Agreement"), by and among all the parties thereto, pursuant to which MHG became a direct, wholly-owned subsidiary of Live Oak (the "Merger"), which subsequently changed its name to Danimer Scientific, Inc. (the "Issuer"), 450,000 shares of the Issuer (the "Holdback Shares") were held back from the merger consideration payable to MHG shareholders at the closing of the Merger until...(continued)

(Continuation of Footnote 1)...the final determination of the merger consideration. On April 18, 2022, following such final determination of the merger consideration in the Merger, an aggregate of 344,435 of the Holdback Shares were released and issued to MHG shareholders, and the Reporting Person received Reporting Person's pro rata portion of such Holdback Shares so issued. The issuance of the shares of the Issuer as merger consideration in the Merger, including the receipt of the Holdback Shares reported on this Form 4, was approved by Issuer's board of directors in December 2020 and is exempt under Rule 16b-3.